SULLIVAN LARA (Chief Executive Officer) received a stock award from PYXIS ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2023ACC: 0001567619-23-000068
DirectorOfficer· Chief Executive Officer
Since Oct 2021
+95.68K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
95.68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+95.68K
Price / share
—
Trade value
—
% of position
7.1%
1/3/2023
1.36M→1.45M
Total
Net shares
+95.68K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | A · Award | +95.68K | — | — | 7.1% | 1.36M | 1.45M |
| Total | +95.68K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported